Skip to content
Medical Health Aged Care

Deadly diarrhoea-causing contaminants may go undetected in flawed testing methods

Monash University 2 mins read

New research has uncovered critical gaps in an emerging global public health tool for detecting environmental faecal contamination - which is linked to life-threatening diarrheal diseases that cause 1.2 million deaths each year. 

Despite being considered globally applicable, microbial source tracking (MST) methods may not be as reliable as assumed, a systematic review found. Health systems that rely on universal methods such as MST risk missing critical opportunities to outbreaks of diarrheal diseases, underscoring the urgent need for standardised approaches.

Lead author Leah Barrett, a PhD candidate at Monash’s RISE program (Revitalising Informal Settlements and their Environments) and based at the Department of Civil Engineering, said an urgent global effort to standardise MST methods to prevent outbreaks is necessary.

“The impact of undetected contamination is devastating as it contributes to the 1.2 million deaths caused by diarrheal diseases each year,” Ms Barrett said.

Ms Barrett said universal tests often fail to accurately identify contamination sources because factors like diet, climate, and local sanitation practices significantly shape the microbial makeup in each region, making it crucial to develop and validate MST markers tailored to these unique conditions.

“The stark regional disparities and a lack of tailored solutions really puts a limit on public health interventions and their ability to prevent deaths worldwide. A valid standardised global testing method is needed urgently,” Ms Barrett said.

“Regionally adapted solutions could transform MST into a powerful tool for combating diarrheal diseases, particularly in vulnerable regions. Without these efforts, MST’s potential to prevent and control these illnesses remains underutilised.”

-ENDS-

https://doi.org/10.1080/10643389.2025.2455031

MEDIA ENQUIRIES:

Courtney Karayannis, Media and Communications Manager

Monash University

T: +61 408 508 454 or Courtney.Karayannis@monash.edu 

Monash University Media | +613 9903 4840 | media@monash.edu 

Visit Monash Lens for expert insights and commentary

 

More from this category

  • Medical Health Aged Care
  • 27/03/2025
  • 08:01
Medibank and Royal Australian College of GPs

$250,000 research grant now open for GPs

The grant will fund up to two projects with a total combined value of $250,000 that focus on preventative care in primary care across any of the following themes: Addressing health inequity and access barriers to preventive care Prevention and early detection of chronic diseases Technology-enabled preventive care and digital health solutions Funding of the grant is being provided through the Medibank Better Health Foundation and the RACGP’s Australian General Practice Research Foundation. Medibank Group Medical Director Dr Shona Sundaraj welcomed the opportunity to partner again with the RACGP. “Primary care is the foundation of the health system and we…

  • Federal Budget, Medical Health Aged Care
  • 26/03/2025
  • 13:55
Australia New Zealand Gynaecological Oncology Group (ANZGOG)

ANZGOG welcomes the Federal Budget’s investment in medical research and clinical trials and highlights the need for continued focus on gynaecological cancers

MEDIA RELEASEFOR IMMEDIATE RELEASE The Australia New Zealand Gynaecological Oncology Group (ANZGOG) welcomes key initiatives in the Federal Budget that will support Australians living with gynaecological cancer. This includes investment in medical research, clinical trials, Pharmaceutical Benefits Scheme (PBS), Medicare and support for our healthcare workers. ANZGOG acknowledges the Federal Government’s commitment of $158.6 million over five years to support medical research and the translation of research into clinical practice, alongside the $150.3 million investment in expanding precision oncology programs, including the Australian Rare Cancers Portal. These investments represent a positive step in strengthening Australia’s healthcare system and advancing cancer…

  • Medical Health Aged Care
  • 26/03/2025
  • 12:22
Royal Australian College of GPs

GPs back Meningococcal B vaccine call

The Royal Australian College of GPs (RACGP) has thrown its support behind 10 Independent NSW MPs calling on the State Government to boost Meningococcal B vaccination rates. The push follows a similar RACGP call made earlier this year, when it urged the Government to protect families across the state by providing free Meningococcal B vaccines to at-risk groups, including children aged two-and-under, and every teen aged 15-19-years-old.   RACGP NSW and ACT Chair, Dr Rebekah Hoffman, backed the call for action. “By providing the Meningococcal B vaccine free of charge for at-risk groups we can save lives across the state,” she…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.